France Services, news and resources from France Tweet Jump to NewsNews in other languagesLibrary resources News Life after the cure People with diabetes or heavy alcohol consumption at higher risk of severe fibrosis after hepatitis C cure Keith Alcorn / 18 May 2022 People with diabetes or high alcohol intake after hepatitis C cure are less likely to experience reductions in liver fibrosis after hepatitis C cure and remained at higher risk of severe liver ... Mother to child Immunoglobulin-free strategy highly effective for prevention of mother-to-child hepatitis B transmission in Cambodia Keith Alcorn / 22 February 2022 A hepatitis B immunuglobulin-free strategy for prevention of mother-to-child hepatitis B transmission is feasible and highly effective in a resource-limited setting if tenofovir is given for at least four weeks prior to delivery, ... Transmission, epidemiology and prevention New cases of hepatitis C declining in people with HIV as access to treatment broadens Keith Alcorn / 21 February 2022 The availability of direct-acting antivirals has led to a 50% reduction in new cases of hepatitis among people with HIV in some high-income settings, a six-country study presented this week ... Hepatitis delta Bulevirtide for hepatitis D proves effective in real-world studies Liz Highleyman / 25 January 2022 The entry inhibitor bulevirtide (Hepcludex) led to a reduction in hepatitis delta virus (HDV) viral load and improved liver enzyme levels in real-world studies in France and Austria, according to findings presented ... Sexual transmission New cases of hepatitis C have fallen among gay and bisexual men with HIV in France Keith Alcorn / 22 October 2021 The rate of new hepatitis C infections halved among gay and bisexual men with HIV in France between 2014 and 2017 following the introduction of direct-acting antivirals, a French cohort study has ... More news News in other languages Canada: Les lignes directrices canadiennes sur la co-infection VIH-VHC arrivent bientôt CATIE / 17 December 2013 Sofosbuvir: De nouvelles associations interpellent Gilead Seronet / 16 December 2013 France: Percée thérapeutique contre l'hépatite C Le Figaro / 11 December 2013 Gilead Sciences, Inc. : L'agence américaine des médicaments (U.S. Food and Drug Administration) approuve le Sovaldi? (sofosbuvir) de Gilead pour le traitement de l'hépatite C chronique Zone Bourse / 10 December 2013 France: VHB et VHC : Journée nationale des patients le 14 décembre Seronet / 10 December 2013 More Library resources Technical supplement - The new psychoactive products Type.pdf Published19 March 2014 Posted byFédération Addiction How to reduce risks with the new psychoactive substances (NPS) Type.pdf Published19 March 2014 Posted byFédération Addiction Prise de position de la SPILF, l’AFEF, la SFLS et la SNFMI sur l’utilisation des inhibiteurs de protéase de 1ere génération du VHC chez les patients co-infectés par le VIH et le VHC de génotype 1 TypeWeb page Published22 March 2013 AuthorSNSMI, SFLS, AFEF, et SPILF AVIS relatif à la vaccination contre la grippe saisonnière chez les personnes atteintes d’une hépatopathie chronique avec ou sans cirrhose TypeWeb page Published22 February 2013 AuthorHaut Conseil de la santé publique View more resources Do you work for a hepatitis organisation?Add your organisation to the listings >